Oulhaj A, Alsuwaidi AR, Suliman A, Gasmelseed H, et al. Admission levels of Soluble Urokinase Plasminogen Activator Receptor (suPAR) Associate with Development of Severe Complications in Hospitalised COVID-19 Patients: A Prospective Cohort Study. Int J Infect Dis 2021 Apr 13. pii: S1201-9712(21)00337.
PMID: 33862208